Yonghe Medical Group Co., Ltd.

Yonghe Medical Group Co., Ltd.

2279.HK
Yonghe Medical Group Co., Ltd.HK flagHong Kong Stock Exchange
2.01
HKD
- -
- -
1.01BMarket Cap
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
1.8
2.35
3.15
5.41
2.75
3.58
3.6
3.62
Basic EPS, GAAP
0.1
0.07
0.31
0.3
-0.17
-1.1
-0.45
0.15
Free Cash Flow per Basic Share
0.11
0.14
0.69
0.62
-0.69
-0.38
0.35
0.95
Dividend per Share
- -
- -
- -
0.17
0.08
- -
- -
- -
Book Value per Share
0.1
0.17
0.48
0.75
0.34
-0.74
-1.19
-1.04
Tangible Book Value per Share
0.39
0.45
0.77
4.13
3.01
1.83
1.37
1.53
Basic Weighted Avg Shares
520
520
520
401
513
496
501
500
Sales/Revenue/Turnover
934
1,224
1,638
2,169
1,413
1,777
1,804
1,808
Operating Margin (%)
14.73
8.29
16.75
11.49
-11.36
-25.36
-6.91
7.28
Depreciation Expense
84
130
159
201
225
335
315
244
Net Income, GAAP
54
36
163
120
-86
-546
-226
74
Effective Tax Rate (%)
51.93
50.19
29.27
42.84
- -
- -
- -
30.24
Profit Margin (%)
5.73
2.91
9.97
5.54
-6.08
-30.74
-12.54
4.08
Working Capital
-53
-102
-68
1,011
691
86
84
304
LT Debt
325
411
683
762
845
773
467
364
Total Equity
203
239
406
1,698
1,585
942
714
787
Return on Invested Capital (%)
- -
6.76
17.85
6.88
- -
- -
- -
6.79
Return on Capital (%)
- -
8.94
21.61
12.33
- -
- -
- -
562.67
Return on Common Equity (%)
- -
50.21
95.84
43.34
-35.85
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
51.42%
10.31%
Free Cash Flow
- -
-68.13%
172.59%
Net Income, GAAP
- -
29.48%
-132.57%
Sales/Revenue/Turnover
- -
5.01%
0.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,777
2024
- -
- -
- -
- -
1,804
2025
- -
- -
- -
- -
1,808

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-1.1
2024
- -
- -
- -
- -
-0.45
2025
- -
- -
- -
- -
0.15

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Yu Zhang
Full Time Employees
3,357
Sector
Healthcare
Industry
Medical - Care Facilities
Address
KunTai International Building Beijing People's Republic of China
IPO Date
Dec 13, 2021
Business
Yonghe Medical Group Co., Ltd. operates as a specialty hair-related healthcare platform in China, delivering a comprehensive range of medical and cosmetic services centered on hair restoration and related therapies. The group maintains a multi-brand and multi-channel model to provide end-to-end solutions for hair health, integrating clinical treatment, medical hair care, and post-treatment maintenance within its ecosystem. Headquartered in Beijing, China, and founded in 2005, the company focuses its operations primarily within the Mainland China market, with a brand matrix that includes Yonghe Medical, Svenson, and related supports for medical wigs and female aesthetic hair transplantation services. The group’s business activities span hair transplantation clinics, specialty Svenson medical hair care centers, female-oriented hair restoration offerings, medical wig products, and associated diagnostic and nursing services. Main products and services - Hair transplantation services: surgical hair restoration procedures performed across a network of clinics, including male and female patterns, with post-operative care programs. - Medical hair care and maintenance: doctor-supervised treatments and regimens designed to slow or reverse hair loss, optimize scalp health, and support transplanted hair. - Routine hair restoration services: non-surgical or minimally invasive options such as PRP therapies, laser/light-based therapies, and ongoing scalp treatments offered under a standardized care pathway. - Medical wigs and related products: provision of medical-grade wigs and related accessories, including bespoke fitting and customization services across brand lines. - Diagnostic and high-touch nursing care: medical testing, diagnosis, and personalized nursing management for hair diseases, delivered through Svenson Medical Hair Care Centers. - Brand-line services and clinics: differentiated offerings under a brand matrix (e.g., Yonghe Medical, Svenson) with specialized clinics and centers targeting distinct customer segments. Latest major company changes - Network optimization and store consolidation: the company restructures its clinic network to optimize performance, closing underperforming locations and concentrating resources on core sites to enhance profitability and efficiency. - Implementation of in-house management systems: deployment of a proprietary medical management platform (internal name and scope reported in market disclosures) that refines operations across multiple processes and improves management precision. - Profitability and margin improvement: following structural adjustments, the company reports improved gross margin and reduced net losses, driven by store rationalization and enhanced operating efficiency, with continued focus on core business lines. - Strategic emphasis on scale and integration: ongoing efforts to deepen the Yonghe Medical brand ecosystem through allied brands (e.g., Svenson, Harvard) and to strengthen medical hair health services in China. Additional context - Industry and segments: healthcare services with a specialized focus on hair-related medical and cosmetic treatments; primary segment is medical service provision for hair health, including surgical and non-surgical interventions. - Target markets: consumers seeking hair restoration and related medical hair care within China, including urban centers with a concentration of clinics and care centers. - Geographic operations: principally in China, with a corporate focus on Beijing as a hub; no substantial reported international clinics. - Founding year and headquarters: founded in 2005; headquarters located in Beijing, China. - Subsidiaries and parent relationships: operates through a branded ecosystem including Yonghe Medical, Svenson Medical Hair Care Centers, and associated brands; maintained as a holding company with a centralized management structure; relationships with local clinics and care centers under the group brand umbrella. Note: Yonghe Medical Group Co., Ltd. is listed on the Hong Kong Stock Exchange (ticker: 2279.HK), with market disclosures noting ongoing restructurings of clinic networks, the roll-out of the group’s in-house management systems, and ongoing brand-driven service expansion within the Chinese market. The company’s public disclosures and market data indicate continued emphasis on core hair transplantation and medical hair care offerings, supported by medical-grade wigs and comprehensive diagnostic services as part of its integrated care model.